<DOC>
	<DOCNO>NCT00750893</DOCNO>
	<brief_summary>This protocol post deal objectives outcome measure primary phase one month post-Dose 2 . This Post Marketing Surveillance ( PMS ) collect safety data use human rotavirus vaccine least 3000 evaluable infant Korea . This study involve male female infant age 6 week time first vaccination . The vaccination course must complete age 24 week .</brief_summary>
	<brief_title>Evaluation Reactogenicity Safety GSK Biologicals ' Rotarix ( Human Rotavirus Vaccine ) Infants</brief_title>
	<detailed_description>The protocol post amend reflect two new vaccine presentation launch Korea . The current PMS thus collect safety information subject receive either Rotarix™ Rotarix™ liquid formulation ( oral suspension prefilled syringe ) course routine clinical practice accord prescribe information Korea .</detailed_description>
	<mesh_term>Rotavirus Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Infants investigator believe parents/guardians comply requirement protocol enrolled PMS . A male female infant age 6 week time first vaccination . Written inform consent obtain parent guardian infant . • At time PMS entry , contraindication precaution use indicated prescribing information check infant must include PMS contraindication . Any change locally approve Prescribing Information must implement immediately .</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>24 Weeks</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Gastroenteritis</keyword>
</DOC>